Related Experiment Video
Updated: Apr 4, 2026
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
Rituximab in refractory sarcoidosis: a single centre experience
Francesco Cinetto1, Nicolò Compagno1, Riccardo Scarpa1
1Clinical Immunology, Department of Medicine-DIMED, Padova University Hospital, via Giustiniani 2, 35128 Padua, Italy.
Rituximab offers a promising treatment for refractory sarcoidosis, a challenging granulomatous disease. This study explores its efficacy in patients unresponsive to standard therapies, including those with lung, eye, and skin involvement.
Area of Science:
- Immunology
- Rheumatology
- Pulmonology
Background:
- Sarcoidosis is a multisystem granulomatous disease with variable prognosis.
- Steroids are first-line treatment, but many patients develop refractory disease.
- Existing treatments for refractory sarcoidosis are limited.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Rheumatic Heart Disease III: Medical Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Tumor Immunotherapy
